|
Presentation by Robert Kerwin - Title to be advised
Prof Robert Kerwin, Institute of Psychiatry, United Kingdom
|
|
New developments in pharmacogenetics
Anil Malhotra, The Zucker Hillside Hospital, United States
|
|
Towards pharmacogenomics: A large-scale association study on response to haloperidol
Dr Dan Rujescu, Ludwig Maximilians University, Germany
|
|
Clinical implications of pharmacogenomics for antipsychotic drug response and induced adverse effects
Daniel J Müller, Neurogenetics Section, Center for Addiction and Mental Health, Canada
|